Tuberculosis (TB) infection causes mortality among People Living with HIV (PLHIV), so the treatment of TB-HIV coinfection is crucial. The study aimed to identify the determinants contributing to TB coinfection among PLHIV in Papua. It is a descriptive-analytic study with a cross-sectional design involving 188 PLHIV at the four hospitals in Papua. CD4+ was carried out using CD4+ counter and viral load using the qPCR technique. A logistic regression test and R statistic with a significance level of 0.05 were used to analyze the determinants of TB coinfection among PLHIV. PLHIV having CD4+ count of fewer than 350 cells/mm3 had a 17.8 times higher risk for TB-HIV coinfection, P-value = 0.0. In addition, a viral load of more than 10 000 copies/ml will be 12.1 times more likely to be co-infected with TB-HIV compared to those who have a viral load of fewer than 10 000 copies/ml, P-value = 0.0. CD4+ markers and viral load are factors that play a role in TB coinfection among PLHIV in Papua Province.
Directorate General Disease Prevention and Control, Ministry of Health Indonesia. Collaboration National Action Plan for TB-HIV Collaboration 2020-2024. Ministry of Health Indonesia. Published 2021. Accessed August 30, 2023. https://tbindonesia.or.id
3.
Technical Service Unit AIDS Tuberculosis Malaria. Papua province HIV/AIDS information (quarter II 2020). Published 2020. www.dinkes.papua.go.id
4.
CribbsSKCrothersKMorrisA.Pathogenesis of HIV-related lung disease: immunity, infection, and inflammation. Physiol Rev. 2020;100(2):603-632. doi:10.1152/physrev.00039.2018
5.
MajumderMTiwariPKPalS.Impact of saturated treatments on HIV-TB dual epidemic as a consequence of COVID-19: optimal control with awareness and treatment. Nonlinear Dyn. 2022;109(1):143-176. doi:10.1007/s11071-022-07395-6
6.
MulugetaTTakaleAUmetaBTerefeB.Active TB infection and its associated factors among HIV-1 infected patients at Jimma Medical Center, Southwest Ethiopia. J Pharm Health Care Sci. 2021;7(44):1-7. doi:10.1186/s40780-021-00228-5
7.
CarranzaCPedraza-SanchezSde Oyarzabal-MendezETorresM.Diagnosis for latent tuberculosis infection: new alternatives. Front Immunol. 2020;11:2006-2013. doi:10.3389/fimmu.2020.02006
8.
ChanieESGelayeGATadesseTY, et al. Estimation of lifetime survival and predictors of mortality among TB with HIV co-infected children after test and treat strategies launched in Northwest, Ethiopia, 2021; a multicentre historical follow-up study. PLoS ONE. 2021;16(12):e0258964. doi:10.1371/journal.pone.0258964
9.
Martin-IguacelRLlibreJMPedersenC, et al. Tuberculosis incidence and mortality in people living with human immunodeficiency virus: a Danish nationwide cohort study. Clin Microbiol Infect. 2022;28(4):570-579. doi:10.1016/j.cmi.2021.07.036
10.
WatersRNdenganeMAbrahamsMRDiedrichCRWilkinsonRJCoussensAK. The Mtb-HIV syndemic interaction: why treating M. Tuberculosis infection may be crucial for HIV-1 eradication. Future Virol. 2020;15(2):101-125. doi:10.2217/fvl-2019-0069
11.
ChandraPGrigsbySJPhilipsJA.Immune evasion and provocation by Mycobacterium tuberculosis. Nat Rev Microbiol. 2022;20(12):750-766. doi:10.1038/s41579-022-00763-4
12.
WongKNguyenJBlairL, et al. Pathogenesis of human immunodeficiency virus-mycobacterium tuberculosis co-infection. J Clin Med. 2020;9(11):3575. doi:10.3390/jcm9113575
13.
Azevedo-PereiraJMPiresDCaladoMMandalMSantos-CostaQAnesE. HIV/Mtb co-infection: from the amplification of disease pathogenesis to an “emerging syndemic.”Microorganisms. 2023;11(4):853. doi:10.3390/microorganisms11040853
14.
FordNMeintjesGVitoriaMGreeneGChillerT.The evolving role of CD4 cell counts in HIV care. Curr Opin HIV AIDS. 2017;12(2):123-128. doi:10.1097/COH.0000000000000348
15.
BaedowiAZulfian RusminiHPrasetiaT.Relationship between the amount of viral load and the incidence of tuberculosis in HIV/AIDS patients receiving ARV therapy (published in Indonesian). ARTERI. 2020;1(3):233-240. Accessed August 30, 2023. https://arteri.sinergis.org/arteri/article/view/76
16.
RakshitSHingankarNAlampalliSV, et al. HIV skews a balanced Mtb-specific Th17 response in latent tuberculosis subjects to a pro-inflammatory profile independent of viral load. Cell Rep. 2020;33(9):108451. doi:10.1016/j.celrep.2020.108451
17.
TesfayeBAlebelAGebrieAZegeyeATesemaCKassieB.The twin epidemics: prevalence of TB / HIV co-infection and its associated factors in Ethiopia; a systematic review and meta-analysis. PLoS ONE. 2018;13(10):e0203986. doi:10.1371/journal.pone.0203986
18.
WalkerNFOpondoCMeintjesG, et al. Invariant natural killer t-cell dynamics in human immunodeficiency virus-associated tuberculosis. Clin Infect Dis. 2020;70(9):1865-1874. doi:10.1093/cid/ciz501
19.
BalukuJBMusaaziJMulwanaRMugaboARBongominFKatagiraW.Prevalence and predictors of CD4+ T-Lymphocytopenia among HIV-negative tuberculosis patients in Uganda. Res Rep Trop Med. 2020;11:45-51. doi:10.2147/rrtm.s252550
20.
LiuJChenXWangJ, et al. Prediction and identification of CD4+ T cell epitope for the protective antigens of Mycobacterium tuberculosis. Med. 2021;100(6):1-11. doi:10.1097/MD.0000000000024619
21.
AmelioPPortevinDHellaJ, et al. HIV infection functionally impairs Mycobacterium tuberculosis-specific CD4 and CD8 T-cell responses. J Virol. 2019;93(5):1-18. doi:10.1128/JVI.01728-18
22.
GeremewDMelkuMEndalamawA, et al. Tuberculosis and its association with CD4+ T cell count among adult HIV positive patients in Ethiopian settings: a systematic review and meta-analysis. BMC Infect Dis. 2020;20(1):1-10. doi:10.1186/s12879-020-05040-4
23.
TambunanBAPriyantoHNugrahaJSoedarsono. CD4+ and CD8+ T-cells expressing interferon gamma in active pulmonary tuberculosis patients. Afr J Infect Dis. 2018;12(suppl 1):49-53. doi:10.21010/Ajid.v12i1S.6
24.
WoldayDKebedeYLegesseD, et al. Role of CD4 / CD8 ratio on the incidence of tuberculosis in HIV-infected patients on antiretroviral therapy followed up for more than a decade. PLoS ONE. 2020;15(5):e0233049. doi:10.1371/journal.pone.0233049
25.
NabatanziRCoseSJolobaMJonesSRNakanjakoD.Effects of HIV infection and ART on phenotype and function of circulating monocytes, natural killer, and innate lymphoid cells. AIDS Res Ther. 2018;15(7):1-8. doi:10.1186/s12981-018-0194-y
26.
WejseCFurtadoACamaraC, et al. Impact of tuberculosis treatment on CD4 cell count, HIV RNA, and p24 antigen in patients with HIV and tuberculosis. Int J Infect Dis. 2013;17(10):e907-e912. doi:10.1016/j.ijid.2013.05.003
27.
DravidANatarajanKMedisettyM, et al. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India. BMC Infect Dis. 2019;19(714):1-12. doi:10.1186/s12879-019-4361-0
28.
BockPJenningsKVermaakR, et al. Incidence of tuberculosis amongst HIV positive individuals initiating antiretroviral treatment at higher CD4 counts in the HPTN 071 (PopART) trial in South Africa. J Acquir Immune Defic Syndr. 2018;77(1):93-101. doi:10.1097/QAI.0000000000001560.Incidence
29.
AlemuABitewZWYesufAZerihunBGetuM.The effect of long-term HAART on the incidence of tuberculosis among people living with HIV in Addis Ababa, Ethiopia: a matched nested case—control study. Infect Drug Resist. 2021;14:5189-5198. doi:10.2147/IDR.S345080
30.
GatechompolSSophonphanJUbolyamS, et al. Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model. BMC Infect Dis. 2022;22(346):1-8. doi:10.1186/s12879-022-07332-3
